mopidamol has been researched along with Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambrus, JL; Biddle, W; Horoszewicz, J; Leong, SS | 1 |
| Cornell, CJ; Forcier, RJ; Forman, WB; Henderson, WG; Martin, JF; Rickles, FR; Van Eeckhout, JP; Zacharski, LR | 1 |
| O'Donnell, MR; Slichter, SJ; Storb, R; Weiden, PL | 1 |
| Ambrus, CM; Ambrus, JL; Gastpar, H | 1 |
| Ambrus, CM; Ambrus, JL; Biddle, W; Gastpar, H; Horoszewicz, J; Huberman, E; Leong, S; Montagna, R | 1 |
| Clark, RL | 1 |
2 review(s) available for mopidamol and Neoplasms
| Article | Year |
|---|---|
Platelets and malignancy. Rationale and experimental design for the VA Cooperative Study of RA-233 in the treatment of cancer.
Topics: Adenocarcinoma; Animals; Anticoagulants; Blood Platelets; Carcinoma, Small Cell; Clinical Trials as Topic; Colonic Neoplasms; Double-Blind Method; Humans; Lung Neoplasms; Mopidamol; Neoplasms; Neoplasms, Experimental; Pyrimidines; Random Allocation | 1982 |
Systemic cancer and the metastatic process.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Cell Adhesion; Cell Membrane; Cell Transformation, Neoplastic; Humans; Macrophages; Mopidamol; Neoplasm Metastasis; Neoplasms; Neoplastic Cells, Circulating; Platelet Aggregation | 1979 |
1 trial(s) available for mopidamol and Neoplasms
| Article | Year |
|---|---|
Platelets and malignancy. Rationale and experimental design for the VA Cooperative Study of RA-233 in the treatment of cancer.
Topics: Adenocarcinoma; Animals; Anticoagulants; Blood Platelets; Carcinoma, Small Cell; Clinical Trials as Topic; Colonic Neoplasms; Double-Blind Method; Humans; Lung Neoplasms; Mopidamol; Neoplasms; Neoplasms, Experimental; Pyrimidines; Random Allocation | 1982 |
4 other study(ies) available for mopidamol and Neoplasms
| Article | Year |
|---|---|
Potentiation of the cell growth inhibitory effect of beta interferon by mopidamole.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cell Division; Cell Line; Drug Synergism; Fibroblasts; Humans; Interferon Type I; Mopidamol; Neoplasms; Pyrimidines | 1984 |
Interruption of tumor-associated platelet consumption with platelet enzyme inhibitors.
Topics: Animals; Blood Platelets; Cell Survival; Cyclooxygenase Inhibitors; Dogs; Enzyme Inhibitors; Fibrinogen; Fibrinolytic Agents; Kinetics; Mopidamol; Neoplasms; Phosphodiesterase Inhibitors; Platelet Count; Sulfinpyrazone; Warfarin | 1982 |
Platelet aggregation inhibitors and metastatic spread of neoplastic cells.
Topics: Animals; Blood Platelets; Female; Humans; Male; Mice; Mopidamol; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Neoplastic Cells, Circulating; Pentoxifylline; Platelet Aggregation; Pyrimidines; Rats; Transplantation, Heterologous | 1982 |
Antimetastatic and antitumor effect of platelet aggregation inhibitors.
Topics: Animals; Female; Humans; Male; Melanoma; Mice; Mopidamol; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Neuroblastoma; Platelet Aggregation; Pyrimidines; Rats; Transplantation, Heterologous | 1982 |